ACM
MRNA icon

Azimuth Capital Management’s Moderna MRNA Stock Holding History

Azimuth Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$208K Hold
1,208
– – 0.01% 311
2021
Q4 		$307K Buy
+1,208
New +$353K 0.01% 287

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Azimuth Capital Management's MRNA Position: Q1 2022 in Review

Azimuth Capital Management held its Moderna (MRNA) position steady in Q1 2022 at 1,208 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #311.

Azimuth Capital Management first reported a position in MRNA in Q4 2021 and has held it in 2 quarters since. The position peaked at $307K in Q4 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Azimuth Capital Management held 1,208 shares of Moderna worth $208K as of Q1 2022.
  • Azimuth Capital Management left its Moderna share count unchanged in Q1 2022.
  • Moderna made up 0.01% of Azimuth Capital Management's portfolio in Q1 2022, its #311 holding.
  • Azimuth Capital Management first reported a position in Moderna in Q4 2021 and has held it in 2 quarters since.
  • Azimuth Capital Management's Moderna position peaked at $307K in Q4 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.